Generic Drugs Market 2027 by Types, Application, Technology, Opportunities, End Users and Regions | The Insight Partners

Generic Drugs Market to 2027 - Global Analysis and Forecasts By Product Type ( Biosimilars, Super Generic and Simple Generic ); Application ( Anti-Infective Drugs, Anti-Arthritis Drugs, Anti-Cancer Drugs, Central Nervous System Drugs, Cardiovascular Drugs, Respiratory Drugs and Other Applications ); Distribution Channel ( Hospitals, Pharmacies, Private Clinics and Other Distribution Channels )

Report Code: TIPRE00003414 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
MARKET INTRODUCTION
Generic drugs are the medications that are developed to be similar to a medicine that is already commercially available in the market with a brand name. The generic drug is similar to the medicine available in terms of dosage, safety and strength, mode of administration, quality and intended use. Due to the similarities, generic drugs are capable of treating various diseases. Generic drugs are most cost effective than the branded ones, hence they are being preferred on a large scale during the recent years.

MARKET DYNAMICS
The generic drugs market is anticipated to grow in the forecast period since they are available at a cost effective price and also offer similar results as their branded counterparts. In addition, the benefits of generic drugs over the macroscopic medicines is expected to offer significant growth opportunities in the market during the forecast period.

MARKET SCOPE
The "Global Generic Drugs Market Analysis to 2027" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of generic drugs market with detailed market segmentation by product type, application, distribution channel and geography. The global generic drugs market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading generic drugs market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION
The global generic drugs market is segmented on the basis of product type, application and distribution channel. Based on product type, the market is segmented as biosimilars, super generic and simple generic. The generic drugs market, based on application is segmented into, anti-infective drugs, anti-arthritis drugs, anti-cancer drugs, central nervous system drugs, cardiovascular drugs, respiratory drugs and other applications. On the basis of distribution channel, the global generic drugs market is segmented into, hospitals, pharmacies, private clinics and other distribution channels.


REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global generic drugs market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The generic drugs market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting generic drugs market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the generic drugs market in these regions.


MARKET PLAYERS

The reports cover key developments in the generic drugs market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from generic drugs market are anticipated to lucrative growth opportunities in the future with the rising demand for generic drugs market in the global market. Below mentioned is the list of few companies engaged in the generic drugs market.

The report also includes the profiles of key generic drugs market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

• Teva Pharmaceutical Industries Ltd.
• Mylan N.V.
• Dr. Reddy's Laboratories Ltd.
• Novartis Pharmaceuticals Corporation
• Apotex Inc.
• Pfizer Inc.
• Endo Pharmaceuticals Inc.
• Fresenius Kabi AG
• Lupin Pharmaceuticals, Inc.
• Cipla Inc.

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Generic Drugs Market - By Product Type
1.3.2 Generic Drugs Market - By Application
1.3.3 Generic Drugs Market - By Distribution Channel
1.3.4 Generic Drugs Market - By Region
1.3.4.1 By Country

2. KEY TAKEWAYS

3. RESEARCH METHODOLOGY

4. GENERIC DRUGS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.3.1 North America - Pest Analysis
4.3.2 Europe - Pest Analysis
4.3.3 Asia-Pacific - Pest Analysis
4.3.4 Middle East and Africa - Pest Analysis
4.3.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS

5. GENERIC DRUGS MARKET - KEY MARKET DYNAMICS

5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

6. GENERIC DRUGS MARKET - GLOBAL MARKET ANALYSIS

6.1. GENERIC DRUGS - GLOBAL MARKET OVERVIEW
6.2. GENERIC DRUGS - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE

7. GENERIC DRUGS MARKET - REVENUE AND FORECASTS TO 2027 - PRODUCT TYPE

7.1. OVERVIEW
7.2. PRODUCT TYPE MARKET FORECASTS AND ANALYSIS
7.3. BIOSIMILARS
7.3.1. Overview
7.3.2. Biosimilars Market Forecast and Analysis
7.4. SUPER GENERIC
7.4.1. Overview
7.4.2. Super Generic Market Forecast and Analysis
7.5. SIMPLE GENERIC
7.5.1. Overview
7.5.2. Simple Generic Market Forecast and Analysis

8. GENERIC DRUGS MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATION

8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. ANTI-INFECTIVE DRUGS
8.3.1. Overview
8.3.2. Anti-Infective Drugs Market Forecast and Analysis
8.4. ANTI-ARTHRITIS DRUGS
8.4.1. Overview
8.4.2. Anti-Arthritis Drugs Market Forecast and Analysis
8.5. ANTI-CANCER DRUGS
8.5.1. Overview
8.5.2. Anti-Cancer Drugs Market Forecast and Analysis
8.6. CENTRAL NERVOUS SYSTEM DRUGS
8.6.1. Overview
8.6.2. Central Nervous System Drugs Market Forecast and Analysis
8.7. CARDIOVASCULAR DRUGS
8.7.1. Overview
8.7.2. Cardiovascular Drugs Market Forecast and Analysis
8.8. RESPIRATORY DRUGS AND OTHER APPLICATIONS
8.8.1. Overview
8.8.2. Respiratory Drugs and Other Applications Market Forecast and Analysis

9. GENERIC DRUGS MARKET - REVENUE AND FORECASTS TO 2027 - DISTRIBUTION CHANNEL

9.1. OVERVIEW
9.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
9.3. HOSPITALS
9.3.1. Overview
9.3.2. Hospitals Market Forecast and Analysis
9.4. PHARMACIES
9.4.1. Overview
9.4.2. Pharmacies Market Forecast and Analysis
9.5. PRIVATE CLINICS
9.5.1. Overview
9.5.2. Private Clinics Market Forecast and Analysis
9.6. OTHER DISTRIBUTION CHANNELS
9.6.1. Overview
9.6.2. Other Distribution Channels Market Forecast and Analysis

10. GENERIC DRUGS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS

10.1. NORTH AMERICA
10.1.1 North America Generic Drugs Market Overview
10.1.2 North America Generic Drugs Market Forecasts and Analysis
10.1.3 North America Market Forecasts and Analysis - By Product Type
10.1.4 North America Market Forecasts and Analysis - By Application
10.1.5 North America Market Forecasts and Analysis - By Distribution Channel
10.1.6 North America Market Forecasts and Analysis - By Countries
10.1.6.1 United States Market
10.1.6.1.1 United States Market by Product Type
10.1.6.1.2 United States Market by Application
10.1.6.1.3 United States Market by Distribution Channel
10.1.6.2 Canada Market
10.1.6.2.1 Canada Market by Product Type
10.1.6.2.2 Canada Market by Application
10.1.6.2.3 Canada Market by Distribution Channel
10.1.6.3 Mexico Market
10.1.6.3.1 Mexico Market by Product Type
10.1.6.3.2 Mexico Market by Application
10.1.6.3.3 Mexico Market by Distribution Channel
10.2. EUROPE
10.2.1 Europe Generic Drugs Market Overview
10.2.2 Europe Generic Drugs Market Forecasts and Analysis
10.2.3 Europe Market Forecasts and Analysis - By Product Type
10.2.4 Europe Market Forecasts and Analysis - By Application
10.2.5 Europe Market Forecasts and Analysis - By Distribution Channel
10.2.6 Europe Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Market
10.2.6.1.1 Germany Market by Product Type
10.2.6.1.2 Germany Market by Application
10.2.6.1.3 Germany Market by Distribution Channel
10.2.6.2 France Market
10.2.6.2.1 France Market by Product Type
10.2.6.2.2 France Market by Application
10.2.6.2.3 France Market by Distribution Channel
10.2.6.3 Italy Market
10.2.6.3.1 Italy Market by Product Type
10.2.6.3.2 Italy Market by Application
10.2.6.3.3 Italy Market by Distribution Channel
10.2.6.4 Spain Market
10.2.6.4.1 Spain Market by Product Type
10.2.6.4.2 Spain Market by Application
10.2.6.4.3 Spain Market by Distribution Channel
10.2.6.5 United Kingdom Market
10.2.6.5.1 United Kingdom Market by Product Type
10.2.6.5.2 United Kingdom Market by Application
10.2.6.5.3 United Kingdom Market by Distribution Channel
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Generic Drugs Market Overview
10.3.2 Asia-Pacific Generic Drugs Market Forecasts and Analysis
10.3.3 Asia-Pacific Market Forecasts and Analysis - By Product Type
10.3.4 Asia-Pacific Market Forecasts and Analysis - By Application
10.3.5 Asia-Pacific Market Forecasts and Analysis - By Distribution Channel
10.3.6 Asia-Pacific Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Market
10.3.6.1.1 Australia Market by Product Type
10.3.6.1.2 Australia Market by Application
10.3.6.1.3 Australia Market by Distribution Channel
10.3.6.2 China Market
10.3.6.2.1 China Market by Product Type
10.3.6.2.2 China Market by Application
10.3.6.2.3 China Market by Distribution Channel
10.3.6.3 India Market
10.3.6.3.1 India Market by Product Type
10.3.6.3.2 India Market by Application
10.3.6.3.3 India Market by Distribution Channel
10.3.6.4 Japan Market
10.3.6.4.1 Japan Market by Product Type
10.3.6.4.2 Japan Market by Application
10.3.6.4.3 Japan Market by Distribution Channel
10.3.6.5 South Korea Market
10.3.6.5.1 South Korea Market by Product Type
10.3.6.5.2 South Korea Market by Application
10.3.6.5.3 South Korea Market by Distribution Channel
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Generic Drugs Market Overview
10.4.2 Middle East and Africa Generic Drugs Market Forecasts and Analysis
10.4.3 Middle East and Africa Market Forecasts and Analysis - By Product Type
10.4.4 Middle East and Africa Market Forecasts and Analysis - By Application
10.4.5 Middle East and Africa Market Forecasts and Analysis - By Distribution Channel
10.4.6 Middle East and Africa Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Market
10.4.6.1.1 South Africa Market by Product Type
10.4.6.1.2 South Africa Market by Application
10.4.6.1.3 South Africa Market by Distribution Channel
10.4.6.2 Saudi Arabia Market
10.4.6.2.1 Saudi Arabia Market by Product Type
10.4.6.2.2 Saudi Arabia Market by Application
10.4.6.2.3 Saudi Arabia Market by Distribution Channel
10.4.6.3 U.A.E Market
10.4.6.3.1 U.A.E Market by Product Type
10.4.6.3.2 U.A.E Market by Application
10.4.6.3.3 U.A.E Market by Distribution Channel
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Generic Drugs Market Overview
10.5.2 South and Central America Generic Drugs Market Forecasts and Analysis
10.5.3 South and Central America Market Forecasts and Analysis - By Product Type
10.5.4 South and Central America Market Forecasts and Analysis - By Application
10.5.5 South and Central America Market Forecasts and Analysis - By Distribution Channel
10.5.6 South and Central America Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Market
10.5.6.1.1 Brazil Market by Product Type
10.5.6.1.2 Brazil Market by Application
10.5.6.1.3 Brazil Market by Distribution Channel
10.5.6.2 Argentina Market
10.5.6.2.1 Argentina Market by Product Type
10.5.6.2.2 Argentina Market by Application
10.5.6.2.3 Argentina Market by Distribution Channel

11. INDUSTRY LANDSCAPE

11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

12. GENERIC DRUGS MARKET, KEY COMPANY PROFILES

12.1. TEVA PHARMACEUTICAL INDUSTRIES LTD.
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. MYLAN N.V.
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. DR. REDDY’S LABORATORIES LTD.
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. NOVARTIS PHARMACEUTICALS CORPORATION
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. APOTEX INC.
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. PFIZER INC.
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. ENDO PHARMACEUTICALS INC.
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. FRESENIUS KABI AG
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. LUPIN PHARMACEUTICALS, INC.
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. CIPLA INC.
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments

13. APPENDIX

13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. Teva Pharmaceutical Industries Ltd.
2. Mylan N.V.
3. Dr. Reddy's Laboratories Ltd.
4. Novartis Pharmaceuticals Corporation
5. Apotex Inc.
6. Pfizer Inc.
7. Endo Pharmaceuticals Inc.
8. Fresenius Kabi AG
9. Lupin Pharmaceuticals, Inc.
10. Cipla Inc.